Nasal polyposis, bronchial asthma and analgesic intolerance.
A retrospective case-control study was conducted in 1042 arbitrarily selected bronchial asthma patients (197 patients with AIA and 845 controls with normal analgesic tolerance). Two thirds of all AIA patients reported one or more diseases in the region of the upper airways. Quite different from the control group, highly significant coincidence of AIA with nasal polyposis (42.6%), paranasal sinus diseases (39%), and chronic rhinitis (42,1%) was recorded in the AIA patients. AIA was characterized by stronger inclination to recurrence of nasal polyps and more frequent negative impact of polypectomy upon the course of asthma. The classical triad of "intrinsic asthma - nasal polyps - analgesic intolerance" was established in 39% of the AIA patients. The pathogenetic factors causing the association of asthma with polyps and the even more strongly association of AIA with polyps are still unknown. The presumed pathogenetic relationship between chronic hyperplastic alterations in the upper airways and the phenomenon of AIA might be caused by disorders in phospholid metabolism (liberation of arachidonic acid, lipoxygenase products, radical mechanisms).
D000700:Analgesics / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology; D004361:Drug Tolerance; D006801:Humans; D009298:Nasal Polyps / Q000150:complications* / Q000601:surgery; D010254:Paranasal Sinus Diseases / Q000150:complications; D012008:Recurrence; D012737:Sex Factors
D000700:Analgesics